Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernand Labrie

Showing results (171-180 of 204) with videos related to

Pageof 21
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 13, 2012
Endogenous sex hormone changes in postmenopausal women in the diabetes prevention programCatherine Kim, Shengchun Kong, Gail A Laughlin, et al.
Psychoneuroendocrinology|July 3, 2016
Testosterone and depressive symptoms among men in the Diabetes Prevention ProgramCatherine Kim, Elizabeth Barrett-Connor, Vanita R Aroda, et al.
Menopause (New York, N.Y.)|November 22, 2012
Reductions in glucose among postmenopausal women who use and do not use estrogen therapyCatherine Kim, Shengchun Kong, Gail A Laughlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancerKaren Liby, Mara Rendi, Nanjoo Suh, et al.
Experimental Dermatology|March 3, 2012
Proteomic analysis identifies new biomarkers for postmenopausal and dry skinCaroline Delattre, Eric Winstall, Christian Lessard, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 2009
Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in menAnna L Eriksson, Mattias Lorentzon, Liesbeth Vandenput, et al.
Menopause (New York, N.Y.)|January 6, 2016
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopauseFernand Labrie, David F Archer, William Koltun, et al.
Hormone Molecular Biology and Clinical Investigation|January 5, 2016
Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label studyCéline Bouchard, Fernand Labrie, Leonard Derogatis, et al.
Menopause (New York, N.Y.)|October 26, 2018
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopauseFernand Labrie, David F Archer, William Koltun, et al.
The Prostate|December 21, 2007
Prostate-specific genes and their regulation by dihydrotestosteroneCi Ma, Ma Ci, Mayumi Yoshioka, et al.
Pageof 21

Showing results (171-180 of 204) with videos related to

Sort By:
Pageof 21
The Journal of Clinical Endocrinology and Metabolism|June 13, 2012
Endogenous sex hormone changes in postmenopausal women in the diabetes prevention programCatherine Kim, Shengchun Kong, Gail A Laughlin, et al.
Psychoneuroendocrinology|July 3, 2016
Testosterone and depressive symptoms among men in the Diabetes Prevention ProgramCatherine Kim, Elizabeth Barrett-Connor, Vanita R Aroda, et al.
Menopause (New York, N.Y.)|November 22, 2012
Reductions in glucose among postmenopausal women who use and do not use estrogen therapyCatherine Kim, Shengchun Kong, Gail A Laughlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancerKaren Liby, Mara Rendi, Nanjoo Suh, et al.
Experimental Dermatology|March 3, 2012
Proteomic analysis identifies new biomarkers for postmenopausal and dry skinCaroline Delattre, Eric Winstall, Christian Lessard, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 2009
Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in menAnna L Eriksson, Mattias Lorentzon, Liesbeth Vandenput, et al.
Menopause (New York, N.Y.)|January 6, 2016
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopauseFernand Labrie, David F Archer, William Koltun, et al.
Hormone Molecular Biology and Clinical Investigation|January 5, 2016
Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label studyCéline Bouchard, Fernand Labrie, Leonard Derogatis, et al.
Menopause (New York, N.Y.)|October 26, 2018
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopauseFernand Labrie, David F Archer, William Koltun, et al.
The Prostate|December 21, 2007
Prostate-specific genes and their regulation by dihydrotestosteroneCi Ma, Ma Ci, Mayumi Yoshioka, et al.
Pageof 21